Michele Pagano

Dr. Michele Pagano is solving complex problems in the field of cellular biology, focusing on the intricate mechanisms of ubiquitin-mediated degradation and its implications for cell cycle control and cancer. As the Chair of the Department of Biochemistry and Molecular Pharmacology and the May Ellen and Gerald Jay Ritter Professor of Oncology at NYU Langone, Dr. Pagano leads a pioneering laboratory dedicated to understanding the ubiquitin system's role in essential cellular processes, such as cell growth and the DNA damage response. Dr. Pagano's research is at the forefront of uncovering how the deregulation of the ubiquitin system contributes to cancer development and progression. His work delves into the molecular intricacies of genome integrity and the pathways that maintain cellular homeostasis. By elucidating these pathways, Dr. Pagano aims to identify novel therapeutic targets for cancer treatment, offering hope for more effective interventions. With a keen interest in molecular pharmacology and cell biology, Dr. Pagano's contributions have significantly advanced our understanding of cancer biology. His research not only sheds light on the fundamental aspects of cell cycle control but also provides insights into potential strategies for combating cancer through targeted therapies. Through his leadership and innovative research, Dr. Pagano continues to make impactful strides in the fight against cancer, inspiring the next generation of scientists in the field.